Vanda Pharmaceuticals
VNDA
#7419
Rank
โ‚ฌ0.37 B
Marketcap
6,36ย โ‚ฌ
Share price
-3.08%
Change (1 day)
47.81%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚ฌ0.11 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.21 Billion. In 2024 the company made an earning of -โ‚ฌ34.31 Million a decrease over its 2023 earnings that were of -โ‚ฌ11.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.11 Billion212.3%
2024 -โ‚ฌ34.31 Million191.43%
2023 -โ‚ฌ11.77 Million-320.45%
2022 โ‚ฌ5.33 M-84.99%
2021 โ‚ฌ35.57 M54.8%
2020 โ‚ฌ22.97 M19.42%
2019 โ‚ฌ19.24 M4.93%
2018 โ‚ฌ18.33 M-228.6%
2017 -โ‚ฌ14.26 Million-8.98%
2016 -โ‚ฌ15.67 Million-53.79%
2015 -โ‚ฌ33.91 Million-30.18%
2014 -โ‚ฌ48.56 Million173.08%
2013 -โ‚ฌ17.78 Million-25.33%
2012 -โ‚ฌ23.82 Million163.61%
2011 -โ‚ฌ9.04 Million-221.15%
2010 โ‚ฌ7.45 M-124.53%
2009 -โ‚ฌ30.4 Million-29.44%
2008 -โ‚ฌ43.08 Million-36.2%
2007 -โ‚ฌ67.53 Million21.81%
2006 -โ‚ฌ55.44 Million170.55%
2005 -โ‚ฌ20.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ27.32 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.85 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.99 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ18.98 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.47 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.77 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.37 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA